|
Post by mnkdfann on Mar 4, 2019 13:26:23 GMT -5
LFD has a new article out attacking the Biomm partnership (among other targets). He does make some interesting points relating to Biomm's size and revenue. I had not realised (or perhaps I had, but had forgotten) just how small a player Biomm is. E.g., revenues of only $217,580.00 US dollars in the past year. Less than a quarter of a million USD in revenues for the year. Some quarters with zero (!) revenue. seekingalpha.com/article/4246149-mannkind-cracking-brazil-nut-caseI know it is a hit piece, but still. I had thought Biomm was much bigger.
|
|
|
Post by awesomo on Mar 4, 2019 15:35:20 GMT -5
Right up there with Tanner. Other than UTHR, every partnership so far has been bogus or a bust.
|
|
|
Post by Clement on Mar 4, 2019 16:10:08 GMT -5
You can't say RLS is bogus or a bust. We just don't know anything yet.
|
|
|
Post by awesomo on Mar 4, 2019 16:28:55 GMT -5
You can't say RLS is bogus or a bust. We just don't know anything yet. The terms of the partnership are extremely cryptic, and considering it's been over three years and there hasn't been any more clarity of what has actually developed, I'm leaning towards bogus. Oh, let's also mention that the CEO of RLS is currently a partner at a law firm specializing in intellectual property.
|
|
|
Post by cretin11 on Mar 4, 2019 17:18:00 GMT -5
I'd go with bust rather than bogus. The partnerships exist, they aren't fake, they just haven't amounted to anything (at least yet). We need one of them to go from bust to boom.
|
|
|
Post by MnkdWASmyRtrmntPlan on Mar 4, 2019 17:18:45 GMT -5
The MJ (Marijuana) business is in its infant state right now. The human endocannabinoid system has essentially just been discovered. Very little is known about it, and it controls so many human symptoms and medical conditions. And Cannabis has the cannabinoids to effect those symptoms and conditions. MJ Strains are now being bred to be rich in the various cannabinoids to address the various symptoms and medical conditions. It is getting to where you can buy individual MJ strains to effect whatever symptom you want. The potential of future benefits are just limitless. Just grabbing a few of the cannabis Effects and Symptoms from the leafly.com/start-exploring page:
EFFECTS: Anxious Aroused Creative Energetic Euphoric Focused Giggly Happy Hungry Relaxed Sleepy Talkative Uplifted
SYMPTOMS: Relieves Cramps Depression Fatigue Headaches Inflammation Insomnia Muscle Spasms Nausea Pain Seizures Stress
Now, imagine if RLS is working on isolating and extracting MJ cannabinoid molecules that address any (or, ALL) of the above Effects or Symptoms and package them into Technosphere cartridges. You could buy Happy Hits, Energetic, Pain, Insomnia, Stress, Fatigue, etc. And each one would filter 10+% royalties to MNKD. And, since MJ is becoming legal, they could probably be sold over-the-counter. This is not your average goldmine. That's a goldmine the size of TEXAS!
Yes, RLS have some talented people on their payroll, and they are taking some time to get going, but RLS and their low-teens royalties are part of the turbo-chargers in the Mannkind rocket-ship. It won't be leaving today and maybe not even tomorrow, but you never know when it will happen. All it will take is one announcement, so you better buckle up to avoid the short-whiplash.
|
|
|
Post by awesomo on Mar 4, 2019 17:36:41 GMT -5
The cannibus industry is one of the hottest spaces for venture capital right now, investors and VCs have pumped $881 million into the space so far as of the end of 2018. It's going to be an extremely crowded, well-funded, and competitive market.
|
|
|
Post by MnkdWASmyRtrmntPlan on Mar 4, 2019 17:44:31 GMT -5
Yes, but we have Al Mann's Technosphere and Andrea Leone-Bay on the payroll. No place that I'd rather be. ... Right here, right now there is no other place I want to be Right here, right now watching the world wake up from history
|
|
|
Post by Thundersnow on Mar 4, 2019 17:59:16 GMT -5
LFD has a new article out attacking the Biomm partnership (among other targets). He does make some interesting points relating to Biomm's size and revenue. I had not realised (or perhaps I had, but had forgotten) just how small a player Biomm is. E.g., revenues of only $217,580.00 US dollars in the past year. Less than a quarter of a million USD in revenues for the year. Some quarters with zero (!) revenue. seekingalpha.com/article/4246149-mannkind-cracking-brazil-nut-caseI know it is a hit piece, but still. I had thought Biomm was much bigger. There was no secret BIOMM is a startup. The key that LFD did not mention is that the MGMT Team of BIOMM are worldwide experienced Big Pharma guys. So actually this could benefit MNKD. You have an experienced team with no LEGACY ISSUES. They have no commitments or TIE UPS in the country. Time will tell.
|
|
|
Post by mnkdfann on Mar 4, 2019 18:14:32 GMT -5
There was no secret BIOMM is a startup. The key that LFD did not mention is that the MGMT Team of BIOMM are worldwide experienced Big Pharma guys. So actually this could benefit MNKD. You have an experienced team with no LEGACY ISSUES. They have no commitments or TIE UPS in the country. Time will tell. A startup? Where on earth did you get that idea from? See mnholdem's post on the first page of this thread. Or Biomm's own website dating its history back to 1975. www.biomm.com/About/HistoryIt is hardly what I would call a startup, even if it has not existed in quite the same form or been operating under the BIOMM name for the entire period since 1975.
|
|
|
Post by sellhighdrinklow on Mar 4, 2019 21:36:59 GMT -5
The cannibus industry is one of the hottest spaces for venture capital right now, investors and VCs have pumped $881 million into the space so far as of the end of 2018. It's going to be an extremely crowded, well-funded, and competitive market. So what. Is any other company working on dry powder as a means of delivery? I actually don't know the answer.
|
|
|
Post by mnkdfann on Mar 4, 2019 21:51:29 GMT -5
The cannibus industry is one of the hottest spaces for venture capital right now, investors and VCs have pumped $881 million into the space so far as of the end of 2018. It's going to be an extremely crowded, well-funded, and competitive market. So what. Is any other company working on dry powder as a means of delivery? I actually don't know the answer. I am not an expert but there appear to be several cannabis powder products on the market. E.g. www.leafscience.com/2017/11/06/cbd-isolate-powder/
|
|
|
Post by seanismorris on Mar 4, 2019 21:53:15 GMT -5
There was no secret BIOMM is a startup. The key that LFD did not mention is that the MGMT Team of BIOMM are worldwide experienced Big Pharma guys. So actually this could benefit MNKD. You have an experienced team with no LEGACY ISSUES. They have no commitments or TIE UPS in the country. Time will tell. A startup? Where on earth did you get that idea from? See mnholdem's post on the first page of this thread. Or Biomm's own website dating its history back to 1975. www.biomm.com/About/HistoryIt is hardly what I would call a startup, even if it has not existed in quite the same form or been operating under the BIOMM name for the entire period since 1975. By that definition, I’m also a “startup” founded in 1976. I’m not sure if that makes me excited or depressed... I think I’d rather be like Microsoft (founded 1975)...
|
|
|
Post by Clement on Jun 27, 2019 10:20:52 GMT -5
Wow! Biomm is $7.10 per share right now. It's gone up a lot since approval was announced 24 days ago.
BIOM3.SA
|
|
|
Post by awesomo on Jun 27, 2019 10:25:31 GMT -5
Wow! Biomm is $7.10 per share right now. What’s your point, it was over 9 like half a year ago.
|
|